当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析 - 现金流量表

迈威生物-U

(688062)

  

流通市值:70.11亿  总市值:153.41亿
流通股本:2.04亿   总股本:4.47亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金124,793,542.94910,664,443.86784,231,938.25484,917,067.43
  收到的税费返还112,735.56---
  收到其他与经营活动有关的现金2,828,099.0484,475,773.3478,534,635.269,865,618.88
  经营活动现金流入小计127,734,377.54995,140,217.2862,766,573.45554,782,686.31
  购买商品、接受劳务支付的现金4,548,985.211,712,770.838,395,722.256,782,481.15
  支付给职工以及为职工支付的现金109,119,532.69477,797,910.92366,163,109.94259,378,037.61
  支付的各项税费4,874,753.7152,122,393.1438,664,708.1210,936,683.63
  支付其他与经营活动有关的现金243,354,277.06743,730,308.73552,574,502.73311,609,944.55
  经营活动现金流出小计361,897,548.661,285,363,383.62965,798,043.04588,707,146.94
  经营活动产生的现金流量净额-234,163,171.12-290,223,166.42-103,031,469.59-33,924,460.63
二、投资活动产生的现金流量:
  收回投资收到的现金6,933,200228,985,135.19181,873,582.1841,873,582.18
  取得投资收益收到的现金474,653.071,241,523.52531,987.94302,196.27
  处置固定资产、无形资产和其他长期资产收回的现金净额-630--
  投资活动现金流入小计7,407,853.07230,227,288.71182,405,570.1242,175,778.45
  购建固定资产、无形资产和其他长期资产支付的现金44,915,404.17157,710,880.15131,275,194.687,210,321.32
  投资支付的现金62,047,994.3271,831,389.99225,635,960.2642,630,877.66
  取得子公司及其他营业单位支付的现金--26,555,538.4812,560,621.08
  投资活动现金流出小计106,963,398.47429,542,270.14383,466,693.34142,401,820.06
  投资活动产生的现金流量净额-99,555,545.4-199,314,981.43-201,061,123.22-100,226,041.61
三、筹资活动产生的现金流量:
  吸收投资收到的现金-200,000,000200,000,000200,000,000
  其中:子公司吸收少数股东投资收到的现金-200,000,000200,000,000200,000,000
  取得借款收到的现金739,980,0002,465,810,0001,285,840,000867,140,000
  发行债券收到的现金85,000,000400,000,000--
  收到其他与筹资活动有关的现金100,000,000200,000,000200,000,000100,000,000
  筹资活动现金流入小计924,980,0003,265,810,0001,685,840,0001,167,140,000
  偿还债务支付的现金564,974,555.632,230,263,124.621,023,767,117.94792,468,562.31
  分配股利、利润或偿付利息支付的现金24,007,044.2378,381,481.0757,896,342.1241,051,813.4
  支付其他与筹资活动有关的现金42,573,258.19165,240,544.3786,929,089.5838,255,764.44
  筹资活动现金流出小计631,554,858.052,473,885,150.061,168,592,549.64871,776,140.15
  筹资活动产生的现金流量净额293,425,141.95791,924,849.94517,247,450.36295,363,859.85
四、汇率变动对现金及现金等价物的影响-2,610,067.84-3,613,540.5-1,291,825.48-153,575.87
五、现金及现金等价物净增加额-42,903,642.41298,773,161.59211,863,032.07161,059,781.74
  加:期初现金及现金等价物余额1,526,339,326.821,227,566,165.231,227,566,165.231,227,566,165.23
  期末现金及现金等价物余额1,483,435,684.411,526,339,326.821,439,429,197.31,388,625,946.97
补充资料:
  净利润--972,257,776.24--552,229,971.82
  资产减值准备-11,264,036.4-7,689,770.12
  固定资产和投资性房地产折旧-177,940,376.07-88,831,754.32
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-177,940,376.07-88,831,754.32
  无形资产摊销-8,043,802.9-3,950,097.2
  长期待摊费用摊销-1,603,412.57-683,533.49
  递延收益摊销-1,139,792.65-307,233.33
  处置固定资产、无形资产和其他长期资产的损失--199,411.91--
  固定资产报废损失-97,022.88--
  公允价值变动损失--1,122,391.35--18,138.89
  财务费用-95,368,255.97-39,669,599.2
  投资损失-9,601,531.63-2,865,785.93
  递延所得税-0-0
  其中:递延所得税资产减少-5,837,014.9-3,242,372.45
    递延所得税负债增加--5,837,014.9--3,242,372.45
  存货的减少-12,521,458.31--6,847,580.81
  经营性应收项目的减少--30,299,881.87--13,076,265.95
  经营性应付项目的增加-366,809,526.68-381,297,671.28
  现金的期末余额-1,526,339,326.82-1,388,625,946.97
  减:现金的期初余额-1,191,693,931.96-1,191,693,931.96
  减:现金等价物的期初余额-35,872,233.27-35,872,233.27
  现金及现金等价物的净增加额-298,773,161.59-161,059,781.74
公告日期2026-04-292026-03-252025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑